We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

150 hedge funds and large institutions have $601M invested in Aerie Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 57 increasing their positions, 45 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

598% more call options, than puts

Call options by funds: $1.69M | Put options by funds: $242K

27% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 45

10% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 20

9% more capital invested

Capital invested by funds: $552M → $601M (+$49.4M)

1% more funds holding

Funds holding: 148 → 150 (+2)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
150
Holders Change
+2
Holders Change %
+1.35%
% of All Funds
2.65%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
22
Increased
57
Reduced
45
Closed
20
Calls
$1.69M
Puts
$242K
Net Calls
+$1.45M
Net Calls Change
+$811K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$8.07M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$4.73M
3
Bank of America
Bank of America
North Carolina
+$3.87M
4
Morgan Stanley
Morgan Stanley
New York
+$3.24M
5
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$3.11M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$14.3M
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$12.8M
3
Goldman Sachs
Goldman Sachs
New York
-$11.3M
4
KCM
Kingdon Capital Management
New York
-$9.93M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$9.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
GIP
26
Granite Investment Partners
California
$6.4M +$660K +54,647 +13%
FCM
27
Frontier Capital Management
Massachusetts
$6.31M -$666K -55,104 -11%
First Manhattan
28
First Manhattan
New York
$6.14M -$292K -24,150 -5%
NAM
29
Nexpoint Asset Management
Texas
$5.98M – – –
N
30
Nuveen
North Carolina
$5.5M -$2.32M -191,751 -32%
Deutsche Bank
31
Deutsche Bank
Germany
$4.89M +$1.09M +90,521 +33%
Citadel Advisors
32
Citadel Advisors
Florida
$4.76M -$6.03M -498,875 -59%
GIM
33
Granahan Investment Management
Massachusetts
$4.51M +$2.81M +232,514 +230%
DCM
34
DAFNA Capital Management
California
$3.9M +$48.3K +4,000 +1%
Renaissance Technologies
35
Renaissance Technologies
New York
$3.87M -$394K -32,590 -10%
Charles Schwab
36
Charles Schwab
California
$3.85M +$33.4K +2,767 +1%
Goldman Sachs
37
Goldman Sachs
New York
$3.47M -$11.3M -932,597 -78%
Norges Bank
38
Norges Bank
Norway
$3.31M -$1.17M -96,746 -28%
AGA
39
Altrinsic Global Advisors
Connecticut
$3.24M +$363K +30,000 +14%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$2.93M -$12.8M -1,058,112 -83%
Fidelity Investments
41
Fidelity Investments
Massachusetts
$2.88M – – –
Alyeska Investment Group
42
Alyeska Investment Group
Illinois
$2.79M -$20K -1,652 -0.8%
IHAM
43
Integral Health Asset Management
New York
$2.7M +$2.42M +200,000 New
Millennium Management
44
Millennium Management
New York
$2.13M +$1.59M +131,591 +502%
Voloridge Investment Management
45
Voloridge Investment Management
Florida
$2.09M -$607K -50,228 -24%
Allianz Asset Management
46
Allianz Asset Management
Germany
$2.06M – – –
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$1.93M +$1.02M +84,158 +143%
HA
48
Homestead Advisers
Virginia
$1.62M -$29K -2,400 -2%
PPA
49
Parametric Portfolio Associates
Washington
$1.43M +$378K +31,310 +42%
DnB Asset Management
50
DnB Asset Management
Norway
$1.41M +$1.26M +104,202 New
1
2
3 4 5

AERI Hedge Fund Activity: Q4 2020 in Review

150 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2020, worth a combined $601M — up 8.9% from $552M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AERI positions and 20 closed out — a net gain of 2 holders — while 57 added to existing stakes and 45 trimmed.

The largest buyer was Deerfield Management, adding an estimated $8.07M. The largest seller was Franklin Resources, exiting entirely with an estimated $14.3M sold.

  • 150 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2020, up from 148 in Q3 2020.
  • Funds reported $601M of Aerie Pharmaceuticals stock for Q4 2020, up 8.9% quarter-over-quarter.
  • 22 funds opened new Aerie Pharmaceuticals positions in Q4 2020 and 20 closed out, a net change of +2 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2020 was Deerfield Management, an estimated $8.07M added.
  • The largest Aerie Pharmaceuticals seller in Q4 2020 was Franklin Resources, an estimated $14.3M sold.

Based on aggregated 13F filings for Q4 2020.